Previous Article | Next Article 
Journal of Clinical Microbiology, January 2001, p. 228-234, Vol. 39, No. 1
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.1.228-234.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Epidemiology and Infection Control Implications of
Acinetobacter spp. in Hong Kong
Elizabeth T. S.
Houang,1,*
Y. W.
Chu,1
C. M.
Leung,1
K. Y.
Chu,1
J.
Berlau,2
K. C.
Ng,1 and
A. F. B.
Cheng1
Department of Microbiology, The Chinese
University of Hong Kong, Prince of Wales Hospital, Shatin NT, Hong
Kong SAR, People's Republic of China,1 and
Department of Ophthalmology, University of Rostock, 18057 Rostock, Germany2
Received 30 March 2000/Returned for modification 12 September
2000/Accepted 17 October 2000
 |
ABSTRACT |
In a previous study, we showed that Acinetobacter
genomic DNA group 3 was the most common species among blood culture
isolates and was commonly found on superficial carriage sites of the
healthy and the sick, which are different findings from those reported in Europe and North America. We used amplified ribosomal DNA
restriction analysis and pulsed-field gel electrophoresis to study
further the molecular epidemiology of acinetobacters in our region.
Over a study period of 6 weeks with 136 consecutive routine clinical isolates (1.33% of all specimens), genomic DNA groups 2 (Acinetobacter baumannii), 3, and 13TU were obtained from
59 of 69 positive patients. There is a significant difference in the
specimen sources of the three genomic DNA groups, with group 13TU being
significantly associated with the respiratory tract (chi-square exact
test, P = 0.0064). Settle plates showed a
significantly heavier environmental load from the intensive care unit
(ICU) than from the four surgical wards examined (22 of 70 versus 76 of
120 plates with <5 colonies; chi-square test, P < 0.0001). Genomic group 3 accounted for 6 of 12 clusters of
possibly related strains among patients, between patients and the ICU
environment, and in the ICU environment. Genomic groups 2 and 3 accounted for 21% of the 132 genomically identified isolates recovered
from 21 of 41 local vegetables, 53 of 74 fish and meat samples, and 22 of 60 soil samples. Group 13TU was present only in patients' immediate
surroundings. The role played by the environment and by human carriage
should be evaluated in order to devise a cost-effective infection
control program pertinent to our situation of acinetobacter endemicity.
 |
INTRODUCTION |
Acinetobacter spp. are
important nosocomial pathogens associated with a growing number of
hospital-acquired infections worldwide (2, 14). In hot,
humid areas, such as Hong Kong, Acinetobacter infection is
endemic, with higher incidences of nosocomial infection, including
bacteremia and pneumonia, than those reported elsewhere (2, 14,
28, 34, 35). The clinically important species, such as
Acinetobacter baumannii (genomic DNA group 2), are
intrinsically resistant to the first-line antimicrobial agents, e.g.,
ampicillin and cefuroxime. Acinetobacter spp. have a
propensity to readily develop resistance to second- and third-line
agents such as cefotaxime, ciprofloxacin, and imipenem, giving rise to
therapeutic problems (2, 30, 32). Outbreaks of
Acinetobacter infections, often caused by multiresistant
strains, have been widely reported, commonly in intensive care units
(ICUs) in North America and Europe. Epidemiological features and risk
factors of these outbreaks have also been well described (2, 5,
8, 10, 14, 16, 17, 18, 20, 24, 36, 43). In contrast, there is a
paucity of information in regions of Acinetobacter
endemicity, such as Hong Kong (28, 34, 35). It has
recently been shown that there is a significant difference between Hong
Kong and Europe in the genomic DNA groups of isolates obtained from
blood cultures and various superficial carriage sites (4, 7,
33). Species other than A. baumannii appear to be of
greater epidemiological significance than was previously appreciated
(7). This raises the question of whether identified risk
factors of infection and control measures that are promulgated and
practiced in areas where the infection is not endemic are wholly
applicable to our region (8, 9, 24, 36, 42). We report
here the molecular epidemiology of isolates obtained from clinical
specimens and compare it with that in the environment both inside and
outside the hospital. We discuss the infection control issues in light
of our findings.
 |
MATERIALS AND METHODS |
The setting.
Prince of Wales Hospital, Shatin, Hong Kong,
People's Republic of China, is a 1,400-bed general hospital built in
1984. There are 10 surgical and 10 medical wards, in addition to wards
of other specialties, with one to two single rooms in most of these 26- to 34-bed wards. There were about 136,000 deaths and discharges in
1998. There is a 22-bed ICU for both medical and surgical cases. There
is an infection control committee and an infection control team, with
two infection control nurses and one infection control doctor.
Infection control practices are largely based on those practiced in the
United Kingdom. Based on laboratory results, particularly of organisms
of infection control interest, or admission diagnoses, the infection
control nurses inform and liaise with the ward staff to ensure that the
right level of isolation and infection control measures are carried
out. Universal precautions are practiced by all health care workers.
Infection control problems are also discussed in clinical meetings.
Isolates from routine clinical specimens.
All acinetobacters
isolated from clinical specimens by the routine laboratory were stored
in nutrient agar slants until examination.
Isolates from hospital environments.
Modified Leeds
Acinetobacter medium (MLAM) containing vancomycin (3 instead of 10 µg/ml) was used as the selective medium for settle plates to sample
the environment of the ICU and four surgical wards (7).
Petri dishes (85-mm diameter) containing MLAM were exposed to the air
at different locations for 6 h continuously in the ICU and for
8 h in the four surgical wards on the day of sampling. The
duration of exposure was determined by previous experiments so as to
achieve discrete colonies with minimal fungal contamination. Repeat
sampling was carried out from the same locations in the wards, at the
same hour and on the same day of the week. The plates were left on the
level surfaces near patients (locker surfaces, windowsills) or on
equipment, e.g., respirators, in such a position that they could not be
disturbed. Representative isolates were stored for genomic DNA
group identification (hereafter referred to as genomic
identification) and studies of clonal relatedness.
Isolates from vegetables, meat, and fish.
Samples of
vegetables, pork, beef, and freshwater fish were purchased from local
markets situated in different districts. Vegetables were aseptically
cut into 1-in. pieces, weighed (5 to 10 g), and placed in 90 ml of
saline in sterile plastic bottles. The meat and fish samples were
weighed and placed in saline (1 g/ml). All samples were then vigorously
shaken for 15 min. Serial dilutions (1:10) were made with the
suspension, and inocula (0.5 ml) in duplicates of these dilutions were
then spread with glass rods onto MLAM plates.
Isolates from soil samples.
Soil samples were obtained from
different areas in Hong Kong. Weighed samples (1 g) were put into
sterile containers with 10 ml of sterile distilled water in each,
stirred to make a suspension, and left to settle for 30 min. The
supernatant (2.5 ml) was then added to 10 ml of enrichment broth
(Oxoid) and incubated at 30°C for 24 h with vigorous shaking.
Serial dilutions (1:10) were made in enrichment broth, and inocula (0.1 ml) of each dilution in duplicates were then spread with glass rods
onto MLAM plates.
Genus identification.
All MLAM plates were incubated at
30°C and examined daily for up to 3 days. Typical colonies were
enumerated, picked, and examined further. Acinetobacter was
identified by Gram staining, cell and colony morphology, activity in
the oxidation/fermentation test, absence of motility, and negative
oxidase and positive catalase reactions. The transformation assay of
Juni was used to confirm the genus (22).
Method of genomic identification.
Genomic
identification was carried out by amplified ribosomal DNA restriction
analysis (ARDRA) as previously described (12), using two
primers (5'-TGG CTC AGA TTG AAC GCT and 5'-TAC CTG TTA CGA CTT CA) and
restriction endonucleases (CfoI, AluI,
MboI, and MspI RsaI [Pharmacia,
Uppsala, Sweden] and BfaI and BsmaI [New England Biolabs, Beverly, Mass.]). Restriction patterns were obtained by agarose (2%) gel electrophoresis and compared after ethidium bromide staining.
Relatedness of strains of the same genomic groups.
Random amplification of polymorphic DNA of groups of strains belonging
to one genomic DNA group was performed with Ready-to-Go random
amplification of polymorphic DNA beads and Primer 2 (both Pharmacia) as
recommended by the manufacturer. Products were analyzed by agarose
(2%) gel electrophoresis.
Enterobacterial repetitive intergenic consensus (ERIC) PCR typing was
performed with the primer ERIC2 (5'-AAG TAA GTG ACT GGG GTG AGC G).
Each reaction (25 µl) contained 50 pmol of the primer, 0.2 mM
deoxynucleoside triphosphates, 1× reaction buffer, 0.25 U of
Taq DNA polymerase (Pharmacia), and 10 to 50 ng of template DNA. Forty-five cycles of 95°C for 60 s, 36°C for 60 s,
and 72°C for 120 s were performed with the reactions before
analysis by 2% agarose gel electrophoresis.
Pulsed-field gel electrophoresis (PFGE) fingerprints were generated
using a contour-clamped homogeneous electric field electrophoresis
apparatus (Bio-Rad, Richmond, Calif.). The restriction endonuclease
ApaI was used for the in situ digestion of intact
Acinetobacter genomic DNA embedded in 1% agarose
gel blocks prepared according
to previously described methods
(
23). Samples were loaded into
1% certified PFGE-grade
agarose gels and electrophoresed with
0.5× Tris-borate-EDTA buffer
(TBE) (50 mM Tris, 40 mM borate,
and 0.5 mM EDTA) with an electric
field of 6 V/cm, an included
angle of 120°C, and a pulse time of 5 to
35 s over 32 h at 14°C.
Images of ethidium bromide solution
(1 mg/liter)-stained gels
were digitized using a gel documentation
system (ImageMaster VDS;
Pharmacia) and analyzed using the computer
software GelCompar
(Applied Maths, Kortrijk, Belgium). Clusters of
possibly related
isolates were identified using the Dice coefficient of
similarity
and unweighted pair group method using arithmetic averages
at
70%, which indicates four- to six-fragment differences in gels
with
an average of 20 bands (
37).
Statistical analyses.
Statistical analyses were carried out
using the chi-square test (Epi Info, version 5.01b) and the chi-square
exact test (StatXact, version 2.05). Unclassifiable strains were
grouped together for analysis.
 |
RESULTS |
Acinetobacters from raw food and soil samples.
Table
1 shows the sources and the number of
samples examined and the distribution of genomic DNA groups of
isolates. Acinetobacters were cultured from 27 of 36 meat samples, 21 of 41 vegetable samples, and 26 of 38 fish samples. These food samples
were tested at regular intervals throughout a period of 12 months. Soil
samples were obtained from 10 sites, with and without human habitation.
This was repeated three times in September 1998 and three times in January 1999. There is a significant difference in the distribution of
genomic DNA groups between the two seasons (chi-square exact test, P = 0.003). Genomic DNA group 3 accounted for
30% of the isolates from the hot season but was not found during
the winter. A significant difference is also seen in comparing the
distribution of genomic DNA groups from vegetables and soil
(winter plus summer) isolates (chi-square exact test, P = 0.0031). Group 2 (A. baumannii) was found in
all environmental sources outside the hospital: vegetables, fish
and meat, and soil, but a large proportion of isolates from these
sources were not classifiable by ARDRA (35 to 51%). From all
environmental sources (both inside and outside the hospital), genomic DNA group 3 was the most common.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Genomic DNA groups of isolates obtained from clinical
specimens and different environments in the hospital and the community
|
|
Acinetobacters from clinical specimens between 26 October and 6 December 1998.
During the period from 26 October to 6 December
1998, in the routine microbiology laboratory at the Prince of Wales
Hospital, Shatin, Hong Kong, People's Republic of China, of the 2,221 sets of blood cultures received, 11 cultures from seven patients
yielded acinetobacters (0.5%). Acinetobacters were also reported in 7 (7 patients) (
105 CFU/ml) of the 4,794 (0.15%) samples
of urine, 76 (55 patients) of the 1,772 (4.3%) respiratory tract
specimens, and 42 (29 patients) of the 1,466 (2.9%) miscellaneous
specimens (bile samples, wound swabs, catheter tips, and tissues). A
total of 97 isolates were collected from 35 patients in the ICU, and 39 isolates from 34 patients were collected from patients in the rest of
the hospital. Nine isolates (one obtained from a catheter tip and eight
from the respiratory tract) from nine ICU patients were not
genomically identified, because one isolate was lost and eight
isolates were from patients who had multiple positive specimens from
the same sources within 3 days. All 39 clinical isolates from the wards and 88 of the 97 ICU isolates were genomically identified
(Table 1). Of the patients examined, clinical isolates from 59 (87%) of them belonged to genomic DNA groups 2, 3, and 13TU.
Table
2 shows the distribution of
genomic DNA groups obtained from different specimen sources.
Although the number of positive
patients is similar for each of the
genomic DNA groups 2, 3, and
13TU, there is a significant
difference in the distribution of
sites from which these
genomic DNA groups were obtained (chi-square
exact test,
P = 0.0064). Group 13TU was significantly associated
with the respiratory tract, being isolated from 19 of 37 respiratory
sites but only 5 of 46 other sites (chi-square test,
P < 0.005;
odds ratio, 4.98; 95% confidence limits, 1.53 to 17.24).
Among
patients with wounds or intravenous catheters,
A. baumannii was
found in 60% (9 of 15) and 45% (5 of 11),
respectively.
Acinetobacters from the ICU and four surgical wards.
Ten
settle plates were placed in a standardized manner as described above
for 6 h on seven weekly occasions in the ICU. Of the 70 plates
used, 67 (96%) yielded acinetobacters, with a range of 1 to 42 colonies per plate. The mean colony counts per location over the 7 weeks ranged from 4 to 19 per plate. All together, 32% of the plates
contained less than 5 colonies, 53% had 5 to 15 colonies, and 15% had
more than 15 colonies. Of the 105 representative isolates saved, 64 from different parts of the ICU were identified to the genomic
level (Table 1).
Forty settle plates were placed in four surgical wards (with a total of
120 beds) at the same times and locations for 8 h
on three
occasions (22 September and 7 and 20 October 1998). Acinetobacters
(range, 1 to 36 colonies) were found on 107 (89%) of the 120 plates
used, with 63% of the plates yielding less than 5 colonies, 32%
yielding 5 to 15 colonies, and 5% yielding more than 15 colonies.
There was a significantly smaller number of plates containing
<5
colonies from the ICU than from the wards (22 of 70 versus
76 of 120)
(chi-square test,
P < 0.0001; odds ratio, 3.77; 95%
confidence limits, 1.93 to 7.42). All 46 isolates obtained on
20 October from the four wards were genomically identified (Table
1).
Relatedness of clinical isolates from the same patients.
Among
the 69 patients, there were 9 patients who had positive specimens from
at least two sites, and in all of them, isolates from different sites
belonged to different genomic DNA groups. Of the 69 patients,
there were 21 sites (19 patients) from which multiple specimens (
2)
from the same sites were positive: 16 respiratory, 2 central
intravenous catheter, 2 blood culture, and 1 wound swab sample. The
results of ARDRA showed that isolates from the same sites belonged to
different genomic DNA groups for 12 of the 19 sites. For
another four sites, the multiple isolates were shown to belong to the
same genomic DNA groups but were different from one another by
ERIC and/or PFGE. In another three sites, the multiple isolates were
shown to be possibly related by PFGE (Dice coefficient of similarity of
70%) (37). Isolates from the remaining two sites were
not examined. Seven patients had
3 positive respiratory specimens,
and in four of them, the same strain was found on at least two occasions.
Relatedness of clinical and environmental isolates obtained from
the ICU.
From the environmental collection, 44 of the 64 genomically identified isolates belonging to genomic
DNA groups 2, 3, 13TU, and an unclassifiable group (U19) were examined
by ERIC PCR and PFGE. The results were compared with those of 68 clinical isolates of the same genomic DNA groups from 29 patients who had multiple specimens or a prolonged stay in the ICU. The
results by PFGE are tabulated in Table 3.
This table shows strains from clinical and environmental sources which
shared a Dice coefficient of similarity of
70% and therefore could
possibly be related (37). There were six clusters of
clinical isolates from different patients, four clusters involving both
environmental and clinical isolates, and two environmental clusters,
each involving two ICU locations. Genomic DNA group 3 was responsible
for 6 of the 12 clusters (Table 3). A. baumannii was
involved in the cluster covering the longest duration (34 days). Figure
1 shows the PFGE dendrogram of isolates belonging to group 13TU, demonstrating two clusters, each involving two
patients and one ICU location.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
ICU clusters found in 76 clinical and environmental
isolates showing Dice coefficients of similarity of 70% by PFGE
for genomic DNA groups 2, 3, and 13TU
|
|

View larger version (64K):
[in this window]
[in a new window]
|
FIG. 1.
Dendrogram and fingerprints of 15 isolates of
genomic DNA group 13TU obtained by PFGE, showing two clusters
of clinical isolates (SLC, SCL, and WC; SA and CKN) and one cluster of
two clinical isolates (FY and SA) with one environmental isolate (E6A),
with a Dice coefficient of similarity of 70%. First column, isolate
identification; second column, date of isolation (year-month-day);
third column, source of isolate. E4B, E6, E6A, environmental isolates;
TA, tracheal aspirate; CIV, central intravenous catheter; SP, sputum.
|
|
 |
DISCUSSION |
Acinetobacter spp. are important nosocomial pathogens
in our region, with a prevalence of infection higher than reported
elsewhere (28, 34, 35). There are many studies in the
literature showing that genomic DNA group 2 (A. baumannii), together with genomic DNA groups 1, 3, and
13TU (known as the Acinetobacter calcoaceticus-A. baumannii
complex [Acb complex]), is predominantly involved in infection (2, 5, 8, 9, 13, 17, 20, 24, 28, 36, 39). Many
of these studies were, however, based on outbreak strains or did not
use reliable methods for genomic identification (18,
40). Our study is the first report using modern genomic identification and nomenclature to study clinical isolates from a
situation where they are endemic. We did not study the clinical significance of positive samples. Others have shown infection rates of
30 to 55% among patients with positive specimens (13, 39). Ng et al. reported that 72% of Acinetobacter
blood cultures were of clinical significance (28). We used
patient-based data to compare the distribution of genomic DNA
groups according to sites and found a significant difference among the
three genomic DNA groups. Genomic DNA group 13TU was
significantly associated with specimens from the respiratory tract.
Genomic DNA groups 2 (A. baumannii) and 3 appeared to be
able to infect, colonize, or contaminate different sites readily.
Genomic DNA group 3 was shown to be the most common species among blood
culture isolates (7). It was the most common species found
on superficial carriage sites among healthy volunteers (7)
and, as shown here, was the most common one in the environment, both
inside and outside the hospital. For hospitalized patients,
genomic DNA group 13TU was the most common species carried in
the throat (31% [reference 7 and our unpublished data])
and, as shown here, was also significantly related to specimens from
the respiratory tract. Genomic DNA group 2 was the most common species
in all other carriage sites sampled from the hospitalized
patients
hairlines, fourth toe webs, groins, and noses
(7). Colonization of hospitalized patients occurs rapidly,
during the first week of stay (13). Our data show that two
or more genomic DNA groups may be isolated from the same
clinical sites on different occasions in some patients. A prospective
clinical study is required to determine whether certain genomic
DNA groups are significantly more likely to be associated with
infection than others at certain sites. If this were the case, it would be helpful for clinical management to genomically identify
acinetobacters from clinical specimens. To this end, a method of
identification which is rapid and easy to perform is required. The
recent use of monoclonal antibodies to identify group 13TU is a
promising development (29).
Heterogeneity among isolates of the same genomic DNA group from
the same site was shown to be a common feature in previous and present
studies (7). Seven patients had multiple respiratory samples yielding acinetobacters of the same genomic DNA group on three or more occasions. For three of these patients, PFGE showed
that different strains were involved. Limitations in the number of
colonies picked from the primary culture for identification might have
exaggerated the picture of heterogeneity. One or more strains may
contaminate, colonize, or infect the sampled site at any one time. The
continuous presence of isolates belonging to two or more
genomic DNA groups or two or more clones of the same
genomic DNA group cannot be excluded. There were other patients whose specimens from wounds or tracheal aspirates consistently yielded
isolates showing similar PFGE and/or ERIC patterns. Repeat isolation of
the same strain(s) may represent a greater likelihood of infection or
colonization than of transient contamination. In outbreaks of infection
caused by an epidemic strain, typing is carried out for containment
measures. For endemic infections, there may be an urgent need to study
virulence markers of strains associated with nosocomial infections.
Their identification would allow the judicious use of antibiotics, an
important measure in the prevention of such infections in the ICU. To
be of practical use, a fast, reliable, and cost-effective method for
typing is required.
There appear to be geographical differences in the distribution of
genomic DNA groups. In Europe and North America, A. baumannii (genomic DNA group 2) is the most common species
found in clinical specimens, and genomic DNA groups 8 and 9 are
the most common ones found in carriage studies. Because of the low
isolation rates of carriage studies, the natural habitat of A. baumannii remains uncertain. A recent study in London reported
that 17% of vegetables (countries of origin not stated) bought from
local supermarkets yielded Acinetobacter spp.,
with genomic DNA groups 2 and 11 being the most common, each
with a frequency of 27% (3). It is therefore suggested
that vegetables may be a habitat for A. baumannii and may
provide a route by which these bacteria are introduced into hospitals.
We showed that A. baumannii and genomic DNA
group 3
the former in small numbers only
can be readily
recovered from all environmental sources: locally grown
vegetables, raw food, soil, and the hospital environment. Raw foods may
be contaminated by a variety of sources and may serve as vehicles of
transmission. We cannot exclude the possibility that some of the
vegetable isolates could have resulted from contamination by handlers,
although we used only the inside leaves for sampling. It is curious
that soil samples taken during the winter from the same locations that
were sampled in the summer did not yield any isolates of
genomic DNA group 3. Genomic DNA group 13TU appears to have a
restricted habitat, being isolated only from human carriage sites
(7), clinical specimens, and patients' immediate
environments. Resistance to desiccation has been well described for
A. baumannii, but information on other species of the
Acb complex is scarce (19, 21, 26). Dry vectors
could be secondary reservoirs during an outbreak and during sporadic
cases (1, 5).
Over the study period for clinical specimens (26 October to 6 December
1998), acinetobacters were isolated from only 3 of the 1,272 patients
admitted to the four surgical wards in which environmental sampling was
undertaken and from 35 of 140 patients in the ICU. The environmental
load in the ICU was significantly higher than in the four surgical
wards, although there was no significant difference in the distribution
of genomic DNA groups. Risk factors, such as antibiotic
therapy, mechanical ventilation, and others, are well described for
Acinetobacter carriage and infections among ICU
patients (2, 8, 10, 14, 17, 18, 20, 24, 36, 42). The
presence of a large number of patients with risk factors and a high
volume of clinical activities, together with other factors in the ICU,
could have contributed to the heavy load of acinetobacters in the
environment. Our results of genomic DNA group identification
indicated that genomic DNA group 3 was the most common species,
accounting for 51.6% (33 of 64) of acinetobacters settling on surfaces
in patients' immediate environments (i.e., environmental
contamination). Comparing our results to those obtained by Gerner-Smidt
in a Danish ICU in a situation where acinetobacters were endemic (1994 to 1995) (15), assuming all other factors were similar,
our settle plates showed a two- to ninefold-higher count. Gerner-Smidt
found 61.5 acinetobacter-carrying particles settling on 1 m2 per h, whereas our mean counts ranged from 117.4 to
557.5 m2 per h (4 to 19 colonies on the plate). In another
ICU study in the United Kingdom regarding surveillance during
non-outbreak situations, air sampling was found to be positive on 4 of
15 occasions (41), whereas we obtained positive samples on
all 7 occasions when we sampled the environment. Thus, when compared
with ICUs in Europe, our unit appears to have a heavier environmental
load of acinetobacters, of which genomic DNA group 3 is the
most common.
There were four clusters of possibly related clinical and environmental
isolates, indicating that the environment is a reservoir (Table 3).
Other clusters (six) contained possibly related isolates from different
patients, indicating cross-transmission among patients. Transmission of
gram-negative rods among ICU patients in a setting where these rods are
endemic was regarded as low, accounting for only 6 to 10% of
clinical isolates (6, 11). Yet we identified eight
clusters (including two with isolates from 2 patients and one location)
of possible cross-transmission among 68 clinical isolates from 29 patients over a period of 6 weeks (Tables 2 and 3). Contrary to
nosocomial infections caused by other gram-negative rods, airborne
sources have been suggested to be important in outbreaks of
Acinetobacter infection (1).
Samples from environmental sources often did not yield any
acinetobacters, although their elimination when detected has been
regarded as an important step toward the control of the outbreak
(1, 5, 10, 18, 20, 39). Acinetobacter-carrying
particles may be skin scales, droplets from respiratory secretions, or
dust (15, 27). The digestive tract has also been shown to
be a reservoir (38). It is not certain whether there is a
critical level of contamination before the environment can be regarded
as a significant reservoir for endemic infections. Given the ready
occurrence of acinetobacters in carriage sites, raw food, and air in
our region, it is unrealistic to aim for the eradication of the
organism from the environment in the ICU. Means to interrupt the
transmission among patients may theoretically be cost effective. Our
ICU is a modern unit, and staff members practice hand washing and
barrier precautions for contact isolation, yet our rates of infection
and colonization remain high. It is uncertain whether regular cleaning
can reduce the environmental load significantly. Other measures may
include the isolation of infected or colonized patients. Rello
suggested that standard preventive measures were inadequate to prevent
Acinetobacter infections in intubated patients
and therefore advocated the conversion of the ICU from open to
individual isolation rooms (31). Mulin et al. reported a
significant reduction in the bronchopulmonary colonization and
infection rates associated with the use of private isolation rooms
among ventilated patients in a surgical ICU (25). The role
of the environment as a source of acinetobacters in cross-transmission among patients in a situation where acinetobacters are endemic, such as
in our ICU, requires clarification before appropriate measures can be devised.
In summary, our findings indicate that genomic DNA groups of
the Acb complex commonly isolated from clinical specimens
can be readily found in the environment both inside and outside the hospital. In clinical specimens, these genomic DNA groups show a preference for certain sites, and genomic DNA group 3, the
most common group in the environment, was as important as A. baumannii. Studies to determine the clinical significance of
genomic DNA groups at different sites and virulence markers of
clinically important strains are required so as to allow the judicious
use of antibiotics in a situation of acinetobacter endemicity. There was evidence of ready cross-transmission of strains among patients and
between patients and the environment. The role played by the environment in areas where acinetobacters are endemic should be evaluated in order to devise a cost-effective program for the control
of nosocomial infections, for example in ICUs.
 |
ACKNOWLEDGMENT |
This study was supported by a grant (4233/97M) from the Research
Grants Council, Hong Kong Special Administrative Region, Hong Kong,
People's Republic of China.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, The Chinese University of Hong Kong, Prince of Wales
Hospital, Shatin NT, Hong Kong SAR, People's Republic of China. Phone:
(852) 2632 2304. Fax: (852) 2647 3227. E-mail:
ehouang{at}cuhk.edu.hk.
 |
REFERENCES |
| 1.
|
Allen, K. D., and H. T. Green.
1987.
Hospital outbreak of multiresistant Acinetobacter anitratus: an airborne mode of spread?
J. Hosp. Infect.
9:110-119[CrossRef][Medline].
|
| 2.
|
Bergogne-Bérézin, E., and K. J. Towner.
1996.
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.
Clin. Microbiol. Rev.
9:148-165[Free Full Text].
|
| 3.
|
Berlau, J.,
H. M. Aucken,
E. T. S. Houang, and T. L. Pitt.
1999.
Isolation of Acinetobacter spp. including A. baumannii from vegetables: implication for hospital-acquired infections.
J. Hosp. Infect.
42:201-204[CrossRef][Medline].
|
| 4.
|
Berlau, J.,
H. M. Aucken,
H. Malnick, and T. L. Pitt.
1999.
Distribution of Acinetobacter spp. on skin of healthy humans.
Eur. J. Clin. Microbiol. Infect. Dis.
18:179-183[CrossRef][Medline].
|
| 5.
|
Catalano, M.,
L. S. Quelle,
P. E. Jeric,
A. Di Martino, and S. M. Maimone.
1999.
Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases.
J. Hosp. Infect.
42:27-35[CrossRef][Medline].
|
| 6.
|
Chetchotisakd, P.,
C. L. Phelps, and A. L. Hartstein.
1994.
Assessment of bacterial cross-transmission as a cause of infections: patients in intensive care units.
Clin. Infect. Dis.
18:929-937[Medline].
|
| 7.
|
Chu, Y. W.,
C. M. Leung,
E. T. S. Houang,
K. C. Ng,
C. B. Leung,
H. Y. Leung, and A. F. B. Cheng.
1999.
Skin carriage of acinetobacters in Hong Kong.
J. Clin. Microbiol.
37:2962-2967[Abstract/Free Full Text]. (Erratum, 37:4206.)
|
| 8.
|
Cisneros, J. M.,
M. J. Reyes,
J. Pachón,
B. Becerril,
F. J. Caballero,
J. L. García-Garmendía,
C. Ortiz, and A. R. Cobacho.
1996.
Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features.
Clin. Infect. Dis.
22:1026-1032[Medline].
|
| 9.
|
Corbella, N.,
M. Pujol,
J. Ayats,
M. Sendra,
C. Ardanuy,
M. A. Domínguez,
J. Liñares,
J. Ariza, and F. Gudiol.
1996.
Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii.
Clin. Infect. Dis.
23:329-334[Medline].
|
| 10.
|
Crowe, M.,
K. J. Towner, and H. Humphreys.
1995.
Clinical and epidemiological features of an outbreak of Acinetobacter infection in an intensive therapy unit.
J. Med. Microbiol.
43:55-62[Abstract/Free Full Text].
|
| 11.
|
D'agata, E.,
L. Venkataraman,
P. de Girolami, and M. Samore.
1997.
Molecular epidemiology of acquisition of ceftazidime-resistant gram-negative bacilli in a nonoutbreak setting.
J. Clin. Microbiol.
35:2602-2605[Abstract/Free Full Text].
|
| 12.
|
Dijkshoorn, L.,
B. van Harsselaar,
I. Tjernberg,
P. J. M. Bouvet, and M. Vaneechoutte.
1998.
Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species.
Syst. Appl. Microbiol.
21:33-39[Medline].
|
| 13.
|
Dy, M. E.,
J. A. Nord,
V. J. LaBombardi, and J. W. Kislak.
1999.
The emergence of resistant strains of Acinetobacter baumannii: clinical and infection control implications.
Infect. Control Hosp. Epidemiol.
20:565-567[CrossRef][Medline].
|
| 14.
|
Forster, D. H., and F. D. Daschner.
1999.
Acinetobacter species as nosocomial pathogens.
Eur. J. Clin. Microbiol. Infect. Dis.
17:73-77.
|
| 15.
|
Gerner-Smidt, P.
1987.
Endemic occurrence of Acinetobacter calcoaceticus biovar anitratus in an intensive care unit.
J. Hosp. Infect.
10:265-272[CrossRef][Medline].
|
| 16.
|
Go, E. S.,
C. Urban,
J. Burns,
B. Kreiswirth,
W. Eisner,
N. Mariano,
K. Mosinka-Snipas, and J. J. Rahal.
1994.
Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam.
Lancet
344:1329-1332[CrossRef][Medline].
|
| 17.
|
Gomez, J.,
E. Simarro,
V. Banos,
L. Requena,
J. Ruiz,
F. Garcia,
M. Canteras, and M. Valdes.
1999.
Six-year prospective study of risk and prognostic factors in patients with nosocomial sepsis caused by Acinetobacter baumannii.
Eur. J. Clin. Microbiol. Infect. Dis.
18:358-361[CrossRef][Medline].
|
| 18.
|
Horrevorts, A.,
K. Bergman,
L. Kollee,
I. Breuker,
I. Tjernberg, and L. Dijkshoorn.
1995.
Clinical and epidemiological investigations of Acinetobacter genospecies 3 in a neonatal intensive care unit.
J. Clin. Microbiol.
33:1567-1572[Abstract/Free Full Text].
|
| 19.
|
Houang, E. T. S.,
R. T. Sormunen,
L. Lai,
C. Y. Chan, and A. S. Y. Leong.
1998.
Effect of desiccation on the ultrastructural appearance of Acinetobacter baumannii and Acinetobacter lwoffii.
J. Clin. Pathol.
51:786-788[Abstract].
|
| 20.
|
Husni, R. N.,
L. S. Goldstein,
A. C. Arroliga,
G. S. Hall,
C. Fatica,
J. K. G. Stoller, and M. Steven.
1999.
Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients.
Chest
115:1378-1382[Abstract/Free Full Text].
|
| 21.
|
Jawad, A.,
H. Seifert,
A. M. Snelling,
J. Heritage, and P. M. Hawkey.
1998.
Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates.
J. Clin. Microbiol.
36:1938-1941[Abstract/Free Full Text].
|
| 22.
|
Juni, E.
1972.
Interspecies transformation of Acinetobacter. Genetic evidence for a ubiquitous genus.
J. Bacteriol.
112:917-931[Abstract/Free Full Text].
|
| 23.
|
Kaufmann, M. E., and T. L. Pitt.
1994.
Pulsed-field gel electrophoresis of bacterial DNA, p. 83-92.
In
Henrik Chart (ed.), Methods in practical laboratory bacteriology. CRC Press, Boca Raton, Fla.
|
| 24.
|
Lortholary, O.,
J. Fagon,
A. B. Hoi,
M. A. Slama,
J. Pierre,
P. Giral,
R. Rosenzweig,
L. Gutmann,
M. Safar, and J. Acar.
1995.
Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis.
Clin. Infect. Dis.
20:790-796[Medline].
|
| 25.
|
Mulin, B.,
C. Bouget,
C. H. Clement,
P. Bailly,
M. Julliot,
J. F. Viel,
M. Thouverez,
I. Vielle,
F. Barale, and D. Talon.
1997.
Association of private isolation rooms with ventilator-associated Acinetobacter baumannii pneumonia in a surgical intensive care unit.
Infect. Control Hosp. Epidemiol.
18:499-503[Medline].
|
| 26.
|
Musa, E. K.,
N. Desai, and M. K. Casewell.
1990.
The survival of Acinetobacter calcoaceticus inoculated on fingertips and on formica.
J. Hosp. Infect.
15:219-227[CrossRef][Medline].
|
| 27.
|
Ng, K. S.,
G. Kumarasinghe, and T. J. Inglis.
1999.
Dissemination of respiratory secretions during tracheal tube suctioning in an intensive care unit.
Ann. Acad. Med. Singapore
28:178-182[Medline].
|
| 28.
|
Ng, T. K. C.,
J. M. Ling,
A. F. B. Cheng, and S. R. Norrby.
1996.
A retrospective study of clinical characteristics of Acinetobacter bacteremia.
Scand. J. Infect. Dis.
101(Suppl.):26-32.
|
| 29.
|
Pantophlet, R.,
L. Brade, and H. Brade.
1999.
Use of a murine O-antigen-specific monoclonal antibody to identify Acinetobacter strains of unnamed genomic species 13 Sensu Tjernberg and Ursing.
J. Clin. Microbiol.
37:1693-1698[Abstract/Free Full Text].
|
| 30.
|
Quinn, J. P.
1998.
Clinical problems posed by multiresistant nonfermenting gram-negative pathogens.
Clin. Infect. Dis.
27(Suppl. 1):S117-S124.
|
| 31.
|
Rello, J.
1999.
Acinetobacter baumannii infections in the ICU: customization is the key.
Chest
115:1226-1229[Free Full Text].
|
| 32.
|
Ruiz, J.,
M. L. Nunez,
J. Perez,
E. Simarro,
L. Martinez-Campos, and J. Gomez.
1999.
Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period.
Eur. J. Clin. Microbiol. Infect. Dis.
18:292-295[CrossRef][Medline].
|
| 33.
|
Seifert, H.,
L. Dijkshoorn,
P. Gerner-Smidt,
N. Pelzer,
I. Tjernberg, and M. Vaneechoutte.
1997.
Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods.
J. Clin. Microbiol.
35:2819-2825[Abstract/Free Full Text].
|
| 34.
|
Siau, H.,
K. Y. Yuen,
P. L. Ho,
S. S. Wong, and P. C. Woo.
1999.
Acinetobacter bacteraemia in Hong Kong: prospective study and review.
Clin. Infect. Dis.
28:26-30[Medline].
|
| 35.
|
Siau, H.,
K. Y. Yuen,
S. S. Y. Wong,
P. L. Ho, and W. K. Luk.
1996.
The epidemiology of Acinetobacter infections in Hong Kong.
J. Med. Microbiol.
44:340-347[Abstract/Free Full Text].
|
| 36.
|
Struelens, M. J.,
E. Carler,
N. Maes,
E. Serruys,
W. G. V. Quint, and A. van Belkum.
1993.
Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting.
J. Hosp. Infect.
25:15-32[CrossRef][Medline].
|
| 37.
|
Tenover, F. C.,
R. D. Arbeit,
R. V. Goering,
P. A. Mickelsen,
B. E. Murray,
D. H. Persing, and B. Swaminathan.
1995.
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.
J. Clin. Microbiol.
33:2233-2239[Free Full Text].
|
| 38.
|
Timsit, J. F.,
V. Garrait,
B. Misset,
F. W. Goldstein,
B. Renaud, and J. Carlet.
1993.
The digestive tract is a major site for Acinetobacter baumannii colonization in intensive care unit patients.
J. Infect. Dis.
168:1336-1337[Medline].
|
| 39.
|
Villari, P.,
L. Iacuzio,
E. A. Vozzella, and U. Bosco.
1999.
Unusual genetic heterogeneity of Acinetobacter baumannii isolates in a university hospital in Italy.
Am. J. Infect. Control
27:247-253[CrossRef][Medline].
|
| 40.
|
Weaver, R. E., and L. A. Actis.
1994.
Identification of Acinetobacter species.
J. Clin. Microbiol.
32:1833[Free Full Text].
|
| 41.
|
Webster, C. A.,
M. Crowe,
H. Humphreys, and K. J. Towner.
1998.
Surveillance of an adult intensive care unit for long-term persistence of a multi-resistant strain of Acinetobacter baumannii.
Eur. J. Clin. Microbiol. Infect. Dis.
17:171-176[Medline].
|
| 42.
|
Weinstein, A. A.
1991.
Epidemiology and control of nosocomial infections in adult intensive care units.
Am. J. Med.
91:S179-S184.
|
| 43.
|
Wisplinghoff, H.,
W. Perbix, and H. Seifert.
1999.
Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case-control study of adult burn patients.
Clin. Infect. Dis.
28:59-66[Medline].
|
Journal of Clinical Microbiology, January 2001, p. 228-234, Vol. 39, No. 1
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.1.228-234.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gundi, V. A. K. B., Dijkshoorn, L., Burignat, S., Raoult, D., La Scola, B.
(2009). Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology
155: 2333-2341
[Abstract]
[Full Text]
-
Karageorgopoulos, D. E., Kelesidis, T., Kelesidis, I., Falagas, M. E.
(2008). Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother
62: 45-55
[Abstract]
[Full Text]
-
Munoz-Price, L. S., Weinstein, R. A.
(2008). Acinetobacter Infection. NEJM
358: 1271-1281
[Full Text]
-
Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., Bonomo, R. A.
(2007). Global Challenge of Multidrug-Resistant Acinetobacter baumannii. Antimicrob. Agents Chemother.
51: 3471-3484
[Full Text]
-
Ecker, J. A., Massire, C., Hall, T. A., Ranken, R., Pennella, T.-T. D., Agasino Ivy, C., Blyn, L. B., Hofstadler, S. A., Endy, T. P., Scott, P. T., Lindler, L., Hamilton, T., Gaddy, C., Snow, K., Pe, M., Fishbain, J., Craft, D., Deye, G., Riddell, S., Milstrey, E., Petruccelli, B., Brisse, S., Harpin, V., Schink, A., Ecker, D. J., Sampath, R., Eshoo, M. W.
(2006). Identification of Acinetobacter Species and Genotyping of Acinetobacter baumannii by Multilocus PCR and Mass Spectrometry. J. Clin. Microbiol.
44: 2921-2932
[Abstract]
[Full Text]
-
Beggs, C. B., Kerr, K. G., Snelling, A. M., Sleigh, P. A.
(2006). Acinetobacter spp. and the Clinical Environment. Indoor and Built Environment
15: 19-24
[Abstract]
-
Leung, W.-S., Chu, C.-M., Tsang, K.-Y., Lo, F.-H., Lo, K.-F., Ho, P.-L.
(2006). Fulminant Community-Acquired Acinetobacter baumannii Pneumonia as a Distinct Clinical Syndrome. Chest
129: 102-109
[Abstract]
[Full Text]
-
Houang, E. T. S., Chu, Y.-W., Lo, W.-S., Chu, K.-Y., Cheng, A. F. B.
(2003). Epidemiology of Rifampin ADP-Ribosyltransferase (arr-2) and Metallo-{beta}-Lactamase (blaIMP-4) Gene Cassettes in Class 1 Integrons in Acinetobacter Strains Isolated from Blood Cultures in 1997 to 2000. Antimicrob. Agents Chemother.
47: 1382-1390
[Abstract]
[Full Text]
-
Houang, E. T. S., Chu, Y. W., Chu, K. Y., Ng, K. C., Leung, C. M., Cheng, A. F. B.
(2003). Significance of Genomic DNA Group Delineation in Comparative Studies of Antimicrobial Susceptibility of Acinetobacter spp.. Antimicrob. Agents Chemother.
47: 1472-1475
[Abstract]
[Full Text]
-
Anstey, N. M., Currie, B. J., Hassell, M., Palmer, D., Dwyer, B., Seifert, H.
(2002). Community-Acquired Bacteremic Acinetobacter Pneumonia in Tropical Australia Is Caused by Diverse Strains of Acinetobacter baumannii, with Carriage in the Throat in At-Risk Groups. J. Clin. Microbiol.
40: 685-686
[Abstract]
[Full Text]